森井生物 (833735.OC)

+ 收藏

利润表(森井生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 21,314,452.3875,926,684.9426,965,648.0365,352,002.2716,552,112.00
 营业收入(元) 21,314,452.3875,926,684.9426,965,648.0365,352,002.2716,552,112.00
二、营业总成本(元) 24,027,337.7976,834,662.3130,624,159.4169,181,873.9221,135,503.82
 营业成本(元) 14,450,038.0656,618,740.1921,022,130.8650,333,369.5513,324,778.98
 研发费用(元) 3,179,959.126,154,034.333,370,876.866,994,354.833,212,701.03
 营业税金及附加(元) 99,797.79388,234.0686,684.00360,363.0672,059.94
 销售费用(元) 1,594,057.682,269,238.91978,241.731,193,772.22374,763.99
 管理费用(元) 4,277,538.5810,424,108.134,602,350.459,512,844.663,981,040.75
 财务费用(元) 425,946.56980,306.69563,875.51787,169.60170,159.13
  其中:利息费用(元) 119,915.82532,846.30295,499.99636,211.56174,752.48
  其中:利息收入(元) 13,319.5338,128.9726,768.8821,196.489,040.52
三、其他经营收益
 加:公允价值变动收益(元) --0.90-17.15-20.25
 加:投资收益(元) -163,740.62-579,853.97-3,586.97-48,660.34-75,268.60
 资产处置收益(元) -127,844.05152,011.43-483,003.431,785.08
 资产减值损失(元) 13,835.98289,808.89630,392.81-3,384,531.8041,572.66
 信用减值损失(元) 533,211.38-276,405.42130,647.04-1,127,244.13-315,839.13
 其他收益(元) 206,260.27503,177.89112,709.68292,677.23244,167.23
四、营业利润(元) -2,123,318.40-843,405.93-2,636,336.49-8,580,651.27-4,686,994.83
 加:营业外收入(元) 193.636,486.985,199.9626,103.0818,207.67
 减:营业外支出(元) 22,836.11154,940.321,107.36251,245.0468,240.74
五、利润总额(元) -2,145,960.88-991,859.27-2,632,243.89-8,805,793.23-4,737,027.90
 减:所得税费用(元) -165,420.13197,499.52-268,522.21-111,447.63-11,936.64
六、净利润(元) -1,980,540.75-1,189,358.79-2,363,721.68-8,694,345.60-4,725,091.26
(一)按经营持续性分类
  持续经营净利润(元) -1,980,540.75-1,189,358.79-2,363,721.68-8,694,345.60-4,725,091.26
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -1,990,222.05-1,099,114.15-2,249,615.49-8,730,896.05-4,725,091.26
  少数股东损益(元) 9,681.30-90,244.64-114,106.1936,550.45-
 扣除非经常性损益后的净利润(元) -1,961,737.04-1,421,956.54-2,478,273.73-8,663,451.61-4,891,605.40
七、每股收益
 一、基本每股收益(元) -0.05-0.03-0.05-0.20-0.11
 二、稀释每股收益(元) -0.05-0.03-0.05-0.20-0.11
八、其他综合收益(元) -79,398.33-66,112.31---
 归属于母公司股东的其他综合收益(元) -79,398.33-66,112.31---
九、综合收益总额(元) -2,059,939.08-1,255,471.10-2,363,721.68-8,694,345.60-4,725,091.26
 归属于母公司所有者的综合收益总额(元) -2,069,620.38-1,165,226.46-2,249,615.49-8,730,896.05-4,725,091.26
 归属于少数股东的综合收益总额(元) 9,681.30-90,244.64-114,106.1936,550.45-
公告日期 2024-08-232024-04-232023-08-282023-04-252022-08-12
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院